Immunogenicity induced by the use of alternative vaccine platforms to deal with vaccine shortages in a low- to middle-income country: Results of two randomized clinical trials
Alejandro Macchia, Daniel Ferrante, María Belén Bouzas, Patricia Angeleri et autres
BACKGROUND: Shortages of component two of Sputnik V vaccine (rAd5) are delaying the possibility of achieving full immunisation. The immunogenic response associated with the use of alternative schemes to complete the scheme was not explored. METHODS: We did two non-inferiority randomized clinical …
ar (code pays fourni par la source)
11 citations
The Lancet Regional Health - Americas